NCT04268706 2023-04-05Phase 2 Study Evaluating Autologous CD30.CAR-T Cells in Patients With Relapsed/Refractory Hodgkin Lymphoma (CHARIOT)Tessa TherapeuticsPhase 2 Active not recruiting97 enrolled
NCT01874054 2019-02-12Study of Brentuximab Vedotin Combined With Bendamustine in Patients With Hodgkin LymphomaSeagen Inc.Phase 1/2 Completed55 enrolled 14 charts